The largest database of trusted experimental protocols

12 protocols using quickplex sq 120 instrument

1

Quantifying SARS-CoV-2 Antibody Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
We measured total binding antibodies against SARS-CoV-2 nucleocapsid (N) and spike (S) receptor binding domain (RBD) in serum using the Elecsys Anti-SARS-CoV-2 and Anti-SARS-CoV-2 S assays, respectively, on a Cobas e601 module analyzer (Roche Diagnostics). Post-infection, both assays should be positive, whereas post-vaccination only the S assay should be positive. Both tests are electro-chemiluminescence sandwich immunoassays, and report results in arbitrary Units/mL. For the S assay, the manufacturer indicates that these arbitrary Unit (U) values can be considered equivalent to WHO-defined international binding antibody units [41 ]. For the S assay, sera were tested undiluted, with samples above the upper limit of quantification (ULOQ) re-tested at 1:100 dilution, allowing a measurement range of 0.4–25,000 U/mL. Anti-RBD binding IgG concentrations in serum were quantified using the V-plex SARS-CoV-2 (IgG) Panel 22 ELISA kit (Meso Scale Diagnostics), which features wild-type and Omicron antigens, on a Meso QuickPlex SQ120 instrument. Sera were diluted 1:10000, with results reported in arbitrary Units/mL.
+ Open protocol
+ Expand
2

Quantification of Aβ Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantification of Aβ38, Aβ40 and Aβ42 was performed with the V-PLEX Aβ peptide Panel 1 kit (K15200E) and a Quickplex SQ120 instrument (MesoScale Discovery) using 25 µl of cell culture supernatant collected at Day 18 of TNF treatment.
+ Open protocol
+ Expand
3

Plasma TNFα Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma was thawed on ice and levels of TNFα in plasma and quantified using the U-PLEX Assay (Meso Scale Discovery, Rockville, MD). The QuickPlex SQ 120 Instrument was used to evaluate cytokine levels (Meso Scale Discovery).
+ Open protocol
+ Expand
4

Cytokine Release Measurement in Fibrosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The levels of cytokines released into the medium on treatment days 13 and 27 were assayed on the MESO QuickPlex SQ 120 Instrument using the Meso Scale Discovery V-PLEX Human Proinflammatory Panel 1 kit according to the manufacturer’s instructions. Samples and standards were prepared with minor modifications as described previously [9 (link)]. Only cytokines previously shown to be involved in modulating fibrogenic processes were analyzed [19 ]. Cytokine data have been deposited in the Dryad Digital Repository and can be downloaded at doi: 10.5061/dryad.5rc1973.
+ Open protocol
+ Expand
5

Multiplex Cytokine Profiling in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
A customized, high-sensitive 10-cytokine U-plex panel (Meso Scale Discovery, Rockville, MMD, USA) was used to analyze plasma levels of IFNβ, IFNγ, IL10, IL1β, IL21, IL6, IL8, IP10, MCP1, and TNFα in cryopreserved plasma samples according to the manufacturer’s protocol. Data were acquired using a QuickPlex SQ 120 instrument (Meso Scale Discovery, Rockville, MD, USA). The lower limit of quantification of each cytokine can be found in Table S2.
+ Open protocol
+ Expand
6

Multiplex Cytokine Profiling in Rodents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Corticosterone (CORT) was measured in duplicate in all samples via EIA according to the manufacturer’s instructions (Enzo Life Sciences, Farmingdale, NY, USA, cat #: ADI-900-097). Samples were run using a 1:40 dilution with intraassay and interassay variations <10%. Circulating cytokines and chemokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IFN-γ, TNF-α, CXCL1 [KC/GRO], CXCL2 [MIP-2α], CXCL10 [IP-10], CCL2 [MCP-1 α], CCL3 [MIP-1]) were measured using a U-PLEX assay (Meso Scale Discovery, Rockville, MD, USA, cat #: K15069L-1) according to the manufacturer’s instructions on a QuickPlex SQ 120 instrument (Meso Scale Discovery, cat #: AI0AA-0, RRID: SCR_020304). Different analytes were measured between experiments based on kit availability at the time the experiment was conducted. All samples were run in duplicate with interassay variations < 10%.
+ Open protocol
+ Expand
7

Isolation and Stimulation of ILC3s

Check if the same lab product or an alternative is used in the 5 most similar protocols
ILC3s were isolated from colonic LPMCs and on average purified to 91.79% purity (Supplemental Figure 2) by sorting using the MoFlo Astrios EQ (Beckman Coulter, Indianapolis, IN). ILC3s were sorted from Viable CD45+ single cell lymphocytes that were Lineage-CD127+CD117+ as described above. Purified ILC3s were then exposed to either 50 ng/mL IL-23 and IL-1β (R & D Systems) or whole bacteria at a ratio of 1 bacteria to 1 ILC3 and incubated for 24 h at 37°C + 5% CO2. Supernatant was collected and saved at −20°C until use. Secreted IL-22 was measured in the supernatant using the IL-22 U-PLEX Assay according to manufacturer's instructions and quantified on the QuickPlex SQ 120 Instrument (Mesoscale Discovery, Rockville, MD).
+ Open protocol
+ Expand
8

Isolation and Cytokine Stimulation of ILC1s and NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ILC1s and NK cells were isolated from colonic LPMCs to greater than 95.8% and 91.5% purity, respectively, by sorting using the MoFlo Astrios EQ (Beckman Colter, Indianapolis, IN). ILC1s were sorted from Viable CD45+ single-cell lymphocytes that were Lineage-CD127+CD117- and NK cells were sorted as Viable CD45+ single-cell lymphocytes that were Lineage-CD127-CD56+. Purified NK cells were plated at 500,000 cells per mL and ILC1s were plated at 100,000 cells per mL in a 96 well plate. Group 1 ILCs were then exposed to either 50ng/mL IL-12p70 (Biolegend) and IL-18 (R & D Systems) or whole bacteria (1 cell:1 bacteria) and incubated for 24 h at 37°C + 5% CO2. Supernatant was collected and saved at −20°C until use. IFNγ was measured in the supernatant using the IFNγ U-PLEX Assay according to manufacturer’s instructions and quantified on the QuickPlex SQ 120 Instrument (Mesoscale Discovery).
+ Open protocol
+ Expand
9

Macrophage-based DENV Infection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inocula were prepared by mixing DENV with antibody dilutions (ADE conditions) or media (virus-only condition) and incubating at 37°C/5% CO2 for 60 minutes to allow for immune complex formation. Supernatants from 6-day monocyte-derived macrophage cultures were aspirated and 200 μL of inoculum added to each well. Plates were rocked to ensure even coverage by the inoculum and incubated for 2 hours at 37°C/5% CO2. After incubation, the inoculum was aspirated, wells were washed twice with 2mL RPMI medium, 500 μL differentiation media added, and plates incubated for 48 hours at 37C/5% CO2. After 48 hours, the supernatant was removed, aliquoted, and stored at -80C for cytokine expression and viral burden analyses. Macrophages were detached from the plates by adding 600 μL of Accutase (Stemcell technologies, 07920) per well and incubated at 37°C for 20 minutes, dissociated by pipetting, transferred to round-bottom polypropylene 96-well plates, and analyzed as described for each respective assay. Cytokine production from DENV infection macrophages was quantified using an MSD QuickPlex SQ120 instrument and a human U-PLEX cytokine panel (Meso Scale Diagnostics).
+ Open protocol
+ Expand
10

Multiplex Cytokine Profiling in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma was thawed on ice and TNFα, IL-6, IFNγ, and IL-1β were quantified by the U-PLEX Assay and CRP was quantified using the V-PLEX Assay according to manufacturer’s instructions (Meso Scale Discovery, Rockville, MD). Both assays were evaluated on the QuickPlex SQ 120 Instrument (Meso Scale Discovery).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!